104 related articles for article (PubMed ID: 12593851)
1. Heparin inhibits SMC growth in the presence of human and fetal bovine serum.
Cindhuchao N; Quinn DA; Garg HG; Hales CA
Biochem Biophys Res Commun; 2003 Feb; 302(1):84-8. PubMed ID: 12593851
[TBL] [Abstract][Full Text] [Related]
2. Sulfation patterns in heparin and heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells.
Garg HG; Yu L; Hales CA; Toida T; Islam T; Linhardt RJ
Biochim Biophys Acta; 2003 Nov; 1639(3):225-31. PubMed ID: 14636954
[TBL] [Abstract][Full Text] [Related]
3. Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation.
Longas MO; Garg HG; Trinkle-Pereira JM; Hales CA
Carbohydr Res; 2003 Jan; 338(3):251-6. PubMed ID: 12543557
[TBL] [Abstract][Full Text] [Related]
4. Effects of heparin on growth factor-induced mitogenic and proliferative responses of rat pulmonary artery smooth muscle cells.
Wang HL; Kilfeather SA; Martin GR; Page CP
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):397-400. PubMed ID: 10322925
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of three commercial heparins on Na+/H+ exchange and growth of PASMC.
Dahlberg CG; Thompson BT; Joseph PM; Garg HG; Spence CR; Quinn DA; Bonventre JV; Hales CA
Am J Physiol; 1996 Feb; 270(2 Pt 1):L260-5. PubMed ID: 8779995
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells.
Garg HG; Thompson BT; Hales CA
Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L779-89. PubMed ID: 11053011
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.
Mrabat H; Garg HG; Hales CA
J Cell Physiol; 2009 Dec; 221(3):603-8. PubMed ID: 19653229
[TBL] [Abstract][Full Text] [Related]
8. Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells.
Wang HL; Kilfeather SA; Martin GR; Page CP
Pulm Pharmacol Ther; 2000; 13(2):53-60. PubMed ID: 10799282
[TBL] [Abstract][Full Text] [Related]
9. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
10. Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.
McCaffrey TA; Falcone DJ; Borth W; Brayton CF; Weksler BB
Biochem Biophys Res Commun; 1992 Apr; 184(2):773-81. PubMed ID: 1315533
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1987 May; 131(2):149-57. PubMed ID: 3495540
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers.
Letourneur D; Logeart D; Avramoglou T; Jozefonvicz J
J Biomater Sci Polym Ed; 1993; 4(5):431-44. PubMed ID: 7694645
[TBL] [Abstract][Full Text] [Related]
13. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum.
Underwood PA; Mitchell SM; Whitelock JM
J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870
[TBL] [Abstract][Full Text] [Related]
14. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cell proliferation.
Joseph PA; Garg HG; Thompson BT; Liu X; Hales CA
Biochem Biophys Res Commun; 1997 Dec; 241(1):18-23. PubMed ID: 9405227
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells.
Lee SL; Wang WW; Joseph PM; Hales CA; Fanburg BL
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):78-83. PubMed ID: 9224212
[TBL] [Abstract][Full Text] [Related]
16. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor.
Benitz WE; Lessler DS; Coulson JD; Bernfield M
J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809
[TBL] [Abstract][Full Text] [Related]
17. Histidine-rich glycoprotein plus zinc reverses growth inhibition of vascular smooth muscle cells by heparin.
Mori S; Shinohata R; Renbutsu M; Takahashi HK; Fang YI; Yamaoka K; Okamoto M; Yamamoto I; Nishibori M
Cell Tissue Res; 2003 Jun; 312(3):353-9. PubMed ID: 12764609
[TBL] [Abstract][Full Text] [Related]
18. Heparin inhibits the progression phase of subcultured endothelial cell proliferation in rat aorta.
Kimura I; Nagaura T; Naitoh T; Kobayashi S; Kimura M
Jpn J Pharmacol; 1992 Dec; 60(4):369-75. PubMed ID: 1287272
[TBL] [Abstract][Full Text] [Related]
19. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
Newcomb PM; Herman IM
J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin.
Underwood PA; Mitchell SM
Cardiovasc Res; 2000 Sep; 47(4):749-58. PubMed ID: 10974223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
